Anavex Life Sciences Corp (AVXL): We need and expect a best effort by all....

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	58
Posts	10144
Boards Moderated	1
Alias Born	09/21/2016

nidan7500

Re: None

Wednesday, 01/11/2023 9:58:36 AM

Wednesday, January 11, 2023 9:58:36 AM

We need and expect a best effort by all.

NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that it will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12th 2023, at the Westin St. Francis in San Francisco, CA. Christopher U Missling, PhD, President & Chief Executive Officer will present the Company in a session scheduled 08:15 AM - 08:55 AM (Pacific Time).

A live audio webcast will be accessible through the Investors section of the Company’s website at www.anavex.com. An archived edition of the session will be available later that day.